DIN 02516667 — TECARTUS 200000000 CELLS
TECARTUS is a suspension of Brexucabtagene autoleucel marketed by GILEAD SCIENCES CANADA INC. The full Brexucabtagene autoleucel monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02516667
- Brand name
- TECARTUS
- Active ingredient
- Brexucabtagene autoleucel
- Strength
- 200000000 CELLS
- Dosage form
- SUSPENSION
- Route
- INTRAVENOUS
- Manufacturer
- GILEAD SCIENCES CANADA INC
- Health Canada status
- MARKETED
- Drug class
- CD19-directed chimeric antigen receptor (CAR) T-cell immunotherapy
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Brexucabtagene autoleucel products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02532719 | TECARTUS | 100000000 CELLS | SUSPENSION | GILEAD SCIENCES CANADA INC | MARKETED |